patients hospital study clinical care infection admission vs mortality severe icu intensive age disease group days higher admitted median unit 
sars-cov sars acute coronavirus respiratory severe syndrome coronaviruses cov human covs spike outbreak identified caused virus novel patients mers-cov highly 
la des et les le en une dans est par du ou virus pour sont plus sur chez cas que 
genetic environmental areas population associated different factors environment urban exposure individuals diversity genes gene genotype area interactions genotypes populations variation 
health virus diseases infectious sars pandemic emerging outbreak epidemic disease influenza public outbreaks ebola global h1n1 threat emergence new spread 
study results significant values high time mean used methods higher studies using compared significantly analysis differences weight research test showed 
mice virus infection viral infected mouse cns mhv strains disease strain hepatitis nervous murine central replication days data coronavirus cells 
structure binding protein structures structural interactions molecular complex studies interaction crystal domain data role sites site different residues form complexes 
viruses viral health virus human emerging infections public global emergence threat new recent review diseases infectious potential spread studies novel 
using mm cells min ph gel rats used buffer ml extraction purified containing electrophoresis rat incubated described concentration performed extracted 
role functions cell cellular review regulation proteins processes including roles protein important pathways involved signaling diseases development key function recent 
genes gene expression analysis expressed identified differentially study infection involved using response data profiles pathways rna revealed cell changes host 
virus human viruses viral hiv type influenza hcv infection infections hepatitis immunodeficiency hiv-1 hbv aids including infected hev rsv different 
patients symptoms cases clinical fever respiratory severe disease acute cough patient days case pneumonia chest ct syndrome diagnosis illness severity 
cases age years rate data group study high higher rates children china compared time incidence groups case significantly aged infection 
ibv virus bronchitis infectious chicken chickens avian strains poultry respiratory strain ib results disease study coronavirus flocks different control vaccine 
health public global international national control countries development capacity response world collaboration support china diseases infectious research regional challenges disease 
cells replication viral activity infection virus effect cell effects expression antiviral treatment study culture results infected vitro viruses rna showed 
bacterial bacteria mucosal oral intestinal health ev71 microbial pathogens gastrointestinal diversity role microbiota enterovirus iga resistance systemic coli human gut 
activity effects extract compounds acid effect antiviral chinese used extracts activities traditional results nucleic study medicine vitro different active herbal 
virus viruses human disease viral infection diseases pathogens family infectious rna isolation cause infections high group pathogen acute animals humans 
pedv diarrhea porcine piglets epidemic virus pigs swine economic mortality industry ped losses pdcov disease infection pig coronavirus sows suckling 
systems studies different research biological understanding disease approach complex molecular important approaches review use interactions provide mechanisms time biology diseases 
infection infected inoculated animals clinical signs group days inoculation virus observed disease groups experimental shedding respiratory different developed showed detected 
pneumonia patients viral cap children community-acquired bacterial cases pathogens viruses etiology diagnosis clinical common study bacteria pathogen mp microbiological higher 
risk age increased high early years rate conditions factors women maternal pregnancy pregnant mortality increase time number rates infants life 
transport function increased species lipid amino membrane levels production apoptosis activity acid uptake increase plasma stress cholesterol serum normal compared 
influenza virus viruses pandemic human h1n1 avian seasonal h7n9 subtypes infections strains infected h5n1 health respiratory subtype flu h3n2 strain 
method prediction using methods used based predict data results predicted accuracy information algorithm model use approach computational set sequence predicting 
virus human infection dna cell ebv cmv viral cytomegalovirus cells herpesvirus early hcmv reactivation epstein-barr latent kshv hsv-1 lytic herpesviruses 
influenza respiratory illness surveillance infection ili infections virus cases study samples acute symptoms sari influenza-like tract viruses severe incidence viral 
detection diagnostic testing tests laboratory use diagnosis clinical test rapid acid pathogens molecular methods used nucleic results sensitivity laboratories specimens 
polymorphisms patients snps infection associated risk genetic susceptibility allele gene polymorphism association genotype role human genes healthy snp controls study 
cells cell virus viral culture infected infection cultures production vitro type strains replication lines vivo isolates isolated plaque high observed 
molecular biology research new understanding review systems information studies provide recent biological development approaches technology analysis tools complex cell applications 
pathogens bacterial bacteria pathogen species viruses diseases infectious identified microbial agents identification identify detection range agent strains multiple microorganisms pathogenic 
vaccine vaccination vaccines virus protection challenge vaccinated responses high immunization antibody immune mucosal protective use oral immunity efficacy live effective 
case presented infection patient examination days symptoms report acute clinical history revealed blood treatment diagnosis reported respiratory fever condition presentation 
cells blood cell cd8 immune cd4 response responses peripheral lymphocytes t-cell vitro study production high results vivo lymphocyte mononuclear function 
cases number estimate estimated data estimates time epidemic reproduction outbreak case model using transmission days rate infections interval outbreaks basic 
entry receptor virus viruses cells binding cell surface host receptors infection attachment use sialic different acid interaction interactions cellular target 
samples infection prevalence positive study rotavirus detected infections collected diarrhea coli results spp fecal calves age diarrhoea group associated tested 
virus respiratory viruses influenza human viral infections rhinovirus hmpv hrv rsv syncytial metapneumovirus parainfluenza tract coronavirus adenovirus common detected rhinoviruses 
influenza virus ha viruses hemagglutinin na viral strains pandemic hi strain neuraminidase m2 iav h1n1 m1 seasonal h1 hemagglutination h5 
tissue tissues lesions viral cells lung organs cases disease changes detected histopathological findings pathology pathological liver organ presence immunohistochemistry present 
infection viral virus entry cell cells receptor binding human host viruses surface receptors role attachment fusion cellular particles membrane proteins 
cells human epithelial cell respiratory airway lung infection type epithelium vitro cf ii different tissue primary tract vivo tissues fibrosis 
cats feline fip cat infection fcov fipv infectious coronavirus disease peritonitis fiv virus felv infected fcv infections domestic type fecv 
health measures interventions control quarantine pandemic influenza effective public social transmission intervention strategies effectiveness impact spread different h1n1 cases isolation 
samples viruses viral virus positive detection respiratory assay pcr patients results testing detected specimens tests clinical study assays rt-pcr diagnostic 
proteins protein mass analysis identified spectrometry identification identify liquid used chromatography using gel novel structural electrophoresis ms study molecular quantitative 
detection high surface dna devices sensors sensor biosensors low based signal sensitivity sensitive biosensor sensing rapid developed microfluidic device range 
ci risk associated factors ratio confidence interval regression odds study analysis data increased compared significantly vs age higher adjusted logistic 
infection different data significant higher studies type significantly associated compared rate study differences results number role time showed large types 
influenza virus avian human h5n1 viruses infection poultry pandemic birds h7n9 subtypes pathogenic high infected subtype highly infections h1n1 humans 
bats bat viruses species coronavirus hosts humans zoonotic natural reservoirs host reservoir mammals fruit different coronaviruses study virus diversity sars-like 
drug drugs antiviral treatment development therapeutic potential use target agents clinical inhibitors new effective targets activity high infections novel approved 
brain cns neurons nervous central disease neuronal studies barrier cells astrocytes microglia bbb degeneration retinal function tissue neurological presence cerebral 
viral viruses host replication virus proteins rna cell infection cellular cycle life mechanisms factors interactions review interaction cells antiviral different 
rna proteins viral virus replication protein viruses genome replicase nonstructural nsp2 nsp1 family coronavirus structural polyprotein non-structural coronaviruses nsp3 nidovirales 
children respiratory infection viral infections severe infants tract associated rsv acute years asthma age disease pediatric severity viruses hospitalized bronchiolitis 
preprint covid-19 license sars-cov-2 allowed medrxiv reserved rights reuse available display granted biorxiv holder international copyright peer-reviewed permission doi coronavirus 
group increased effects groups control days dose effect study results treatment increase time treated significant significantly compared administration rate rats 
respiratory children patients infections viruses infection samples detected study viral positive results hbov tract pcr nasopharyngeal pathogens years cases clinical 
use approach used high method number screening methods multiple using large single time new different small development based low techniques 
dna pcr rna fragments gene using primers reaction sequence amplified chain primer fragment polymerase sequences cdna used bp different reverse 
antibody antibodies serum virus vaccination days immune higher titers compared sera levels response responses protection significantly vaccine neutralization group challenge 
covid-19 sars-cov-2 virus coronavirus infection patients china cases infected health disease outbreak wuhan pandemic novel infections confirmed spread transmission public 
virus la des le et les en une est dans par elsevier du ou pour plus sont chez cas sas 
cells cell human tissue vitro tissues studies mice vivo high liver stem lines function protein line culture spinal model role 
rna viral mrna translation dna cells viruses rnas expression gene mrnas initiation structure human genes cellular transcription transcripts nuclear small 
research health risk framework management analysis issues paper different development new process systems policy public human challenges key important need 
article et al data access research authors open original license text distributed version work creative terms provided use distribution commons 
species animals animal human humans zoonotic host transmission wild infection hosts pathogens wildlife livestock health including associated range domestic populations 
protein sequence genome reading sequences gene open orf proteins amino genes frame orfs acid frames region rna virus expression nt 
medicine time research veterinary information years medical conditions different new important problem various recent period events healthy past common attention 
sequence phylogenetic sequences genetic analysis genome evolutionary data evolution strains lineage recombination origin analyses study diversity time tree showed gene 
transmission network control patterns data population networks epidemic spread outbreak spatial disease contact distribution different individuals information role outbreaks dynamics 
human models animal studies model disease species study use experimental used understanding research humans development provide review new data infectious 
study results group methods significant psychological higher compared groups effects rate significantly days effect time used using quality showed mental 
disease infection cases virus epidemic outbreak infected viral outbreaks countries high reported cause pathogens case severe previously mortality acute symptoms 
fed feed milk feeding diet protein intake effects daily dietary bw replacer weight data effect gain treatments weaning greater wk 
diseases disease disorders diabetes metabolic failure risk heart associated chronic acute cardiovascular autoimmune type cause liver conditions including high function 
delivery different nanoparticles cells acid peptide properties peptides nucleic cell applications systems delivered formulations targeting therapeutic formulation molecules potential efficacy 
protein recombinant proteins cells expressed expression purified western using coli analysis blot fusion assay study antibodies purification results viral native 
sequence sequences genome species dna proteins protein genes human different gene family expression genomes structure group function regions genomic analysis 
protein receptor binding rbd spike domain entry human sars-cov viral receptor-binding s1 infection residues cells coronavirus virus cell ace2 glycoprotein 
human activity effects effect levels treatment serum antiviral vitro increased plasma dose vivo peptide peptides concentrations treated increase administration rats 
study health knowledge participants risk results high survey data public factors nurses methods questionnaire conducted practices using associated information respondents 
pneumoniae bacterial pathogens pneumonia streptococcus aureus bacteria mycoplasma staphylococcus infection pathogen respiratory influenzae mrsa haemophilus pneumococcal influenza cap isolates agents 
patients levels serum plasma higher compared healthy blood significantly study controls concentrations group increased results significant subjects protein concentration associated 
cells proteins protein membrane infected er associated cell assembly virions virion particles different release membranes microscopy data envelope studies formation 
infections viral infection respiratory bacterial diagnosis resistance bacteria use clinical pathogens treatment antimicrobial diagnostic tract antibiotic antibiotics resistant microbial blood 
ebov ebola gp virus filovirus ebolavirus gps viruses filoviruses fever glycoprotein outbreak africa hemorrhagic disease marburg infection gp2 humans marv 
strains strain isolates analysis gene sequence isolated amino sequences s1 genes showed phylogenetic genetic spike acid china revealed isolate identified 
mers-cov infection cases middle east mers respiratory syndrome coronavirus transmission saudi arabia case virus outbreak control reported epidemic contact outbreaks 
different associated interactions group interaction number model similar structure present reported types previously patterns related complex features large type systems 
patients recipients transplantation transplant infection risk cell hematopoietic mortality infections hct stem disease hsct treatment rejection allogeneic donor organ immunocompromised 
data model method analysis using used time approach different based models use studies methods results information study new developed prediction 
activity compounds ic inhibitors inhibitory antiviral compound inhibition showed potent ec screening respectively active activities assay inhibitor human values cell 
analysis method different methods used detection using samples results study sample protocol use quantitative techniques mass based control range levels 
rotavirus viruses diarrhea fecal virus human enteric diarrhoea group coronavirus feces studies ii faecal groups astrovirus gastroenteritis pathogens bovine children 
compounds activities metabolites studies species natural plant used different activity properties quercetin medicinal pharmacological various active isolated flavonoids glycyrrhizin research 
mice protein vaccine responses immune immunization dna induced immunized antibody adjuvant response recombinant humoral proteins antibodies immunogenicity neutralizing cells results 
food water production human use health consumption safety natural products waste produced animals bacterial risk environmental exposure animal environment information 
model infection models population disease infected epidemic diseases infectious outbreak dynamics individuals time rate transmission outbreaks mathematical parameters populations modeling 
infections viral infection disease viruses diseases pathogens infectious virus pathogen cause diagnosis review bacterial associated role risk common clinical agents 
nanoparticles properties microscopy chemical applications particles surface electron materials nanoparticle viruses nm used nps size synthesis high different silver stability 
review new technology applications development technologies clinical diseases infectious research recent methods use application approaches tools human techniques current advances 
mers-cov respiratory middle east human mers syndrome coronavirus infection virus camels cases dpp4 humans camel dromedary transmission infections disease saudi 
fusion viral membrane proteins protein virus peptide peptides domain glycoprotein envelope membranes cell viruses transmembrane formation conformational class structure form 
health mortality disease world people deaths public diseases infectious million burden countries year worldwide morbidity cause increased rate cases population 
cells cell immune responses infection response cd8 viral immunity cd4 infections antigen memory nk virus role antigens innate lymphocytes effector 
sensitivity specificity diagnosis test patients value positive results negative diagnostic clinical high used study using use methods predictive detection respectively 
activity nuclear antiviral transcription factor activation proteins pathway signaling kinase dsrna nucleus rnase binding demonstrate phosphorylation protein activities inhibition genes 
treatment clinical patients use studies therapy effects trials effect effective therapeutic used efficacy combination drug role antiviral conditions outcomes potential 
health social risk public media communication factors information associated behaviour behavior use coverage perceived risks effects research news group outbreak 
ace2 angiotensin ace ii ang enzyme ras role receptor type renin-angiotensin angiotensin-converting cardiovascular axis hypertension lung effects blood converting pressure 
treatment group clinical days study trial groups randomized placebo participants control effects cold common day duration therapy primary efficacy effect 
respiratory acute patients severe ards lung syndrome ventilation mechanical oxygen pneumonia failure pulmonary mortality distress pressure intubation high therapy care 
expression cells protein study results cell effect significantly inhibited activity reduced demonstrated induced showed levels increased human inhibition mrna activation 
virus viruses viral selection genetic high evolution codon usage rate different host evolutionary species rna mutations low mutation bias diversity 
vaccine vaccines development control infection vaccination viral infections effective use protection health challenge strains disease new potential live time novel 
rna replication synthesis virus viral translation polymerase rnas genome transcription subgenomic role rdrp genomic vitro viruses studies pol mrnas leader 
sars patients sars-cov acute respiratory severe syndrome coronavirus infection days early outbreak samples healthy antibody controls study day subjects antibodies 
treatment mice patients human infection development therapy vitro activity clinical model effective vivo therapeutic antiviral models data high mouse animal 
sars acute respiratory severe syndrome outbreak epidemic outbreaks coronavirus cases hong kong transmission disease patients control early diseases infectious infection 
infection protein cells replication viral virus cell role expression host infected proteins rna cellular study results important effect studies data 
protein binding structure proteins structural interactions structures model complex studies function interaction crystal molecular molecules small study functional results target 
bovine cattle respiratory herds virus bcov calves bcv brsv viral disease bvdv herd animals brd dairy coronavirus tract milk diarrhea 
ace2 renal kidney enzyme angiotensin-converting activity cells urine receptor urinary angiotensin levels expression aki tubular converting expressed ckd serum shedding 
air ventilation indoor wind building study room dispersion different buildings model airborne flow source rooms effects rate airflow environment pollutant 
surveillance data health disease systems information diseases infectious public outbreaks monitoring reporting epidemic use outbreak detection used early using reports 
airborne air aerosol particles transmission human aerosols filter particle influenza sampling respiratory infectious diseases droplets viruses exhaled filters pathogens droplet 
frameshifting ribosomal frameshift prf pseudoknot rna sequence structure ribosome trna codon sites slippery mrna site programmed downstream stem-loop efficiency frame 
data information database available software analysis used research using tools search databases provide tool multiple provides single users annotation web 
clinical vaccines vaccine research development diseases infectious natural products pathogens trials effective strategies novel guidelines potential new disease develop pathogen 
proteins cell protein cells human function different functions cellular membrane including disease lipid mechanisms conditions regulation processes data control pathways 
lectin glycosylation lectins glycans glycoproteins glycan carbohydrate n-linked glycoprotein high c-type glycosylated mbl recognition n-glycans oligosaccharides binding activity carbohydrates grft 
diseases infectious infections countries risk travel infection recovery disease malaria factors dengue hiv asia international region tb european europe chloroquine 
virus inactivation infectivity viruses viral ml light inactivated time tio log tcid transmission dose infectious hand uv cv min study 
dogs canine dog parvovirus cpv virus cdv ccov type distemper cpv-2 infection coronavirus ccv crcov puppies dna pathogens caninum high 
proteins activity ubiquitin enzymes isg15 modification modifications human role dub target post-translational functions antiviral protein e3 cellular ubiquitination substrates dubs 
viruses virus viral species family rna dna human identified samples sequencing sequence sequences genome novel identify identification members study genus 
cancer cell cells tumor human patients tumors growth breast treatment lines prostate proliferation survival lung cancers clinical line melanoma therapy 
elsevier rights form source centre free long resource analyses original means database research covid-19 repositories unrestricted permissions granted acknowledgement covid 
coronavirus coronaviruses human respiratory virus viruses group rna species family groups infectious diseases tract spike strains hcov related tgev different 
infection control patients transmission risk healthcare workers infections hospital hcws patient hospitals contact prevention disease care health factors staff measures 
health human diseases infectious disease control public emerging animals global animal risk humans factors environmental policy zoonotic areas change new 
mice infection virus infected viral mouse lung type high treatment vitro model mortality compared vivo higher dose days replication lethal 
patients patient treatment diagnosis care management use clinical medical control diagnostic early therapy mortality resistance cases effective prevention used antimicrobial 
immune receptors response responses receptor cells innate recognition pathogens activation signaling toll-like immunity pattern host ligands tlr4 tlr pathogen tlr3 
studies high different data results number study use effects large type low increased time effect used higher approach cases production 
resistance bacterial strains bacteria antimicrobial infections strain antibiotic coli isolates antibiotics resistant pathogens type different activity clinical pneumoniae tm isolated 
ifitm3 proteins viruses ifitm virus restriction transmembrane influenza ifitm1 antiviral ifitms human ifit1 activity inhibit expression entry tetherin ifit cells 
proteins production protein gene expression cells genes recombinant use high produced cell vector vectors used expressed expressing dna viral using 
peptide epitopes peptides epitope protein proteins antigenic cell human vaccine identified class immune study sequence conserved binding amino b-cell antigen 
viral sequencing viruses virus genome rna samples sequence sequences using reads novel genomes metagenomic human identification identify identified ngs next-generation 
chronic patients copd exacerbations respiratory lung disease pulmonary infection acute exacerbation asthma obstructive airway associated sputum increased function tract bronchitis 
review research recent years studies different current new discuss past role understanding molecular important use systems knowledge mechanisms focus decades 
et al text abstract publisher pubmed free plos citation type med iii clin dis infect van ii sci article en 
virus dengue denv infection fever viruses zikv human ns1 health chikv infections flaviviruses rna zika flavivirus mosquito disease chikungunya pathogens 
care health patients medical patient healthcare hospital public critical hospitals management workers emergency clinical physicians time facilities response staff resources 
viral development drug drugs vaccines vaccine antiviral potential new health effective therapeutic infections novel emerging human agents control treatment pathogens 
vaccines vaccine development antigen immune antigens immunity responses human viral effective use clinical protective diseases pathogens infectious dna response induce 
antibodies antibody monoclonal neutralizing mabs human mab epitopes epitope different specific activity neutralization virus infection polyclonal infected antigenic binding using 
genes gene human cell expression dna early ii nuclear transcription function mrna genetic previously reported associated screening number single multiple 
samples viral infection virus positive rna detected load collected days time infected blood tested high swabs specimens study results shedding 
activity group synthesis hz dna derivatives groups synthesized ring reaction acid nucleoside position analogues ch antiviral amino rna viruses range 
ion channel protein ca virus channels transmembrane ions calcium membrane domain viroporins metal data lipid activity tm model acute p7 
genetic genes gene expression phenotypes human strains phenotypic cc analysis identified chromosome susceptibility strain identify traits identification phenotype loci locus 
cells inflammatory macrophages inflammation production role immune response cytokines cytokine macrophage activation cell lps lung complement monocytes neutrophils acute responses 
time china tourism economic effects cost market policy countries effect costs impact change global industry travel rate years study hong 
studies study results different role information disease time methods type used diseases infectious reported important presence previously identified present range 
la des et les en le dans du par une pour sont sur est que ou ont au plus ces 
cases china covid-19 wuhan sars-cov-2 coronavirus early virus measures days control interventions spread case novel confirmed epidemic quarantine outbreak time 
assay detection pcr real-time rt-pcr assays samples rna developed using sensitivity rapid sensitive detect multiplex clinical reaction quantitative method results 
rate higher temperature compared effects significantly increased time different conditions rates ph effect high lower results increase optimal growth low 
ifn type interferon antiviral response viral infection immune innate signaling genes induction gene production ifns virus rig-i responses cells immunity 
studies data review articles literature published study systematic research results search using methods information included evidence analysis used different identified 
research health review public guidelines medicine human recommendations knowledge information use current field scientific recent associated veterinary role used discuss 
sirna rna rnai gene interference sirnas silencing genes interfering expression targeting small target protein rnas using short therapeutic cells specific 
fig figure data rabies shown table supplementary analysis values red mean et blue s1 al using spike number green cases 
samples analysis strains genetic sequence positive detected gene phylogenetic strain study showed sequences revealed different identified collected china related new 
protein domain proteins activity amino domains role sites site acid mutations region type residues results study motif mutation vitro presence 
mice role expression results demonstrate mechanisms increased activation type associated mechanism effect effects factor important enhanced macrophages required inflammation signaling 
cytokines cytokine infection immune expression infected levels response production increased role inflammatory il-6 significantly il-10 responses higher compared blood protein 
infection lung disease respiratory severe virus acute infected viral replication human associated syndrome pulmonary models studies severity cause animal pneumonia 
pathogens diseases human infectious transmission pathogen disease risk emerging host infections agents hosts factors population contact emergence new humans global 
virus viruses replication attenuated virulence protein recombinant rna mutations gene reverse infectious genome genetics clone genes expression cdna vitro attenuation 
data associated risk high study incidence significant factors health studies time results analysis number patterns different increased low observed used 
disease studies immune mechanisms events conditions data function changes occur clinical infection cause associated early response population responses result evidence 
pigs porcine virus swine prrsv pig reproductive respiratory syndrome type disease csfv viruses suis tgev fever prrs pcv2 ppv study 
infection immune host viral response responses infections viruses innate role mechanisms cellular pathogens immunity studies different factors important understanding control 
interactions protein interaction data proteins human network identified identify identification complex analysis networks systems approach functions biological role diseases infectious 
detection amplification assay probes probe dna rt-lamp isothermal pcr reaction method lamp sensitivity sensitive rapid developed using detect real-time rt-pcr 
calves calf diarrhea colostrum dairy days mortality parvum neonatal cryptosporidium cows age control group farm treatment management study birth day 
ms demyelination disease sclerosis myelin cns multiple autoimmune demyelinating patients central encephalomyelitis csf nervous chronic inflammatory lesions matter eae cells 
disease development review treatment research clinical mortality cause recent new health current potential effective therapeutic infection vaccine causes novel vaccines 
elisa antibodies igg assay protein antibody sera serum detection immunosorbent antigen enzyme-linked samples virus using igm infection test specific used 
